Skip to main content
Conferences and Meetings 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster II

732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster II

Short name: updated-732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster II-2025 Annual Meeting Poster Bundle Immune Regulation & Therapies
Course start date: 02/17/2026

Sections

General
0 activities

Monte Carlo simulation of HLA DQ heterodimers and their interactions to predict relapse and GVHD risk in cord blood transplantation
Allogeneic hematopoietic cell transplantation risk stratification and eligibility using race neutral versus race specific pulmonary equations
Clearance of RAS pathway mutations prior to allogeneic transplant in Acute Myeloid Leukemia are associated with favorable overall and leukemia free survival
Fapi PET CT as an innovative imaging tool for monitoring bone marrow fibrosis and treatment response in myelofibrosis patients undergoing allogeneic stem cell transplantation
Acrobat interim results Alloheme surveillance enables early detection of relapse in post HCT AML and MDS patients
Outcomes of elderly ≥ 70 Acute Myeloid Leukemia AML patients receiving continued hypomethylating agent venetoclax HMA VEN versus allogeneic hematopoietic cell transplantation HCT
Predicting algorithm for GRFS after allogeneic hematopoietic stem cell transplantation A study by the SFGM TC
The evaluation of the HLA KIR interaction models may predict the NK alloreactivity in haplo HSCT based on ptcy Experience of a single spanish center
Impact of pre transplant chemotherapy cycles on allogeneic hematopoietic cell transplant outcomes in pediatric acute myeloid leukemia
Predictors of outcomes to allogeneic hematopoietic cell transplantation allo HCT for TP53 mutant myelodysplastic neoplasms MDS and acute myeloid leukemia AML patients and impact of hypomethylating agent HMA maintenance therapy
Clinical impact of predicted indirectly recognizable HLA epitopes PIRCHE in single unit cord blood transplantation using tacrolimus and methotrexate for graft versus host disease prophylaxis
Maintenance treatment with gilteritinib suppresses post transplant relapse in relapsed refractory FLT3 mutated acute myeloid leukemia A Japanese nationwide registry study
Early TCR diversity and recipient stem cell persistence predict relapse and reveal therapeutic targets after allogeneic transplantation

Vimeo Vimeo
13